Former FDA Chief Talks COVID-19 Vaccine Future At Process Progress

Thermo Fisher Scientific’s Process Progress event, held virtually on June 9, 2021, convened industry experts from across the biomanufacturing space to explore the unique challenges inherent in developing today’s cutting-edge therapeutics. With presentations representing an array of unique industry perspectives – from materials scientists to market analysts to tech transfer experts – Process Progress focused on offering attendees insight into the supply chain hurdles, technology innovations, and opportunities that define the space today.

The event’s keynote interview featured Dr. Scott Gottlieb, former commissioner of the FDA, whose focus on patient access and regulatory advancement during his tenure resulted in a record-setting number of approvals of novel drugs, medical devices, and generic medicines. Dr. Gottlieb, in conversation with Daniella Cramp, senior vice president and president of the BioProduction Group at Thermo Fisher Scientific, discussed the evolving opportunities within the biomanufacturing space, including the advancements in messenger RNA (mRNA) vaccines that facilitated global response to the COVID-19 pandemic.